ArticleAntimicrobial agents and chemotherapy2022

Reply to Epling and Powers, "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients".

Marco Falcone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.